🇺🇸 Sancuso patch in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 20
Most-reported reactions
- Nausea — 4 reports (20%)
- Vomiting — 3 reports (15%)
- Diarrhoea — 2 reports (10%)
- Disease Progression — 2 reports (10%)
- Malignant Neoplasm Progression — 2 reports (10%)
- Vertigo — 2 reports (10%)
- Weight Decreased — 2 reports (10%)
- Abdominal Pain — 1 report (5%)
- Asthenia — 1 report (5%)
- Atelectasis — 1 report (5%)
Other Oncology approved in United States
Frequently asked questions
Is Sancuso patch approved in United States?
Sancuso patch does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Sancuso patch in United States?
LG Life Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.